0 CHECKOUT

Navamedic ASA (NAVA) - Financial and Strategic SWOT Analysis Review

  • ID: 1323075
  • June 2016
  • 41 pages
  • GlobalData
1 of 4

Navamedic ASA (NAVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies READ MORE >

Note: Product cover images may vary from those shown
2 of 4

List of Tables

List of Figures

Section 1 - About the Company

Navamedic ASA - Key Facts

Navamedic ASA - Key Employees

Navamedic ASA - Key Employee Biographies

Navamedic ASA - Major Products and Services

Navamedic ASA - History

Navamedic ASA - Company Statement

Navamedic ASA - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 - Company Analysis

Navamedic ASA - Business Description

Navamedic ASA - Corporate Strategy

Navamedic ASA - SWOT Analysis

SWOT Analysis - Overview

Navamedic ASA - Strengths

Strength - Business Performance: Consumer Care

Strength - Core Segment: Pharma

Strength - Strategic Partnerships

Navamedic ASA - Weaknesses

Weakness - High Cost Structure

Navamedic ASA - Opportunities

Opportunity - New Product Launches

Opportunity - Acquisition of Observe Medical International AB

Opportunity - New Agreements

Navamedic ASA - Threats

Threat - Intense Competition

Threat - Uncertain R&D Outcomes

Threat - Stringent Government Regulations

Navamedic ASA - Key Competitors

Section 3 - Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 - Company’s Lifesciences Financial Deals and Alliances

Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016

Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016

Navamedic ASA, Recent Deals Summary

Section 5 - Company’s Recent Developments

May 11, 2016: Navamedic: Q1 2016 Results

Feb 18, 2016: Navamedic announces Strong Sales - Product Launch Affected Profitability

May 26, 2015: Navamedic strengthens product area Female Care

Apr 28, 2015: Navamedic first quarter results 2015

Feb 27, 2015: Navamedic Announces fourth quarter report 2014

Section 6 - Appendix

Methodology

Ratio Definitions

About

Contact Us

Disclaimer

List of Tables

Navamedic ASA, Key Facts

Navamedic ASA, Key Employees

Navamedic ASA, Key Employee Biographies

Navamedic ASA, Major Products and Services

Navamedic ASA, History

Navamedic ASA, Subsidiaries

Navamedic ASA, Key Competitors

Navamedic ASA, Ratios based on current share price

Navamedic ASA, Annual Ratios

Navamedic ASA, Interim Ratios

Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016

Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016

Navamedic ASA, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

Navamedic ASA, Performance Chart (2011 - 2015)

Navamedic ASA, Ratio Charts

Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016

Navamedic ASA, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016

Note: Product cover images may vary from those shown
3 of 4

Weifa ASA
Vingmed AS
Immunocorp Consumer Health
Bluefish Pharma Incentive AB

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Cache

Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.